S958 Pharmacogene CYP1A2*1F Polymorphism Lowers Anti-TNF (infliximab) Response in Inflammatory Bowel Disease Patients
American Journal of Gastroenterology | October 24, 2021 | Volume: 116 | Issue: 1 | Pages: S458-S458
10.14309/01.ajg.0000777364.76967.26